These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Nandivada P; Cowan E; Carlson SJ; Chang M; Gura KM; Puder M Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):153-8. PubMed ID: 23602846 [TBL] [Abstract][Full Text] [Related]
30. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. Rangel SJ; Calkins CM; Cowles RA; Barnhart DC; Huang EY; Abdullah F; Arca MJ; Teitelbaum DH; J Pediatr Surg; 2012 Jan; 47(1):225-40. PubMed ID: 22244423 [TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease. Pastor-Clerigues A; Marti-Bonmati E; Milara J; Almudever P; Cortijo J PLoS One; 2014; 9(12):e115404. PubMed ID: 25502575 [TBL] [Abstract][Full Text] [Related]
32. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease. Cowan E; Nandivada P; Puder M Curr Opin Pediatr; 2013 Apr; 25(2):193-200. PubMed ID: 23407182 [TBL] [Abstract][Full Text] [Related]
33. Role of the Gut Microbiota in Parenteral Nutrition-Associated Liver Disease: From Current Knowledge to Future Opportunities. Jiang L; Wang Y; Xiao Y; Wang Y; Yan J; Schnabl B; Cai W J Nutr; 2022 Feb; 152(2):377-385. PubMed ID: 34734271 [TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients. Cahová M; Daňková H; Heczková M; Brátová M; Ďásková N; Baštová H; Gojda J; Wohl P Physiol Res; 2019 Aug; 68(4):681-688. PubMed ID: 31177800 [TBL] [Abstract][Full Text] [Related]
35. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Nandivada P; Chang MI; Potemkin AK; Carlson SJ; Cowan E; Oʼloughlin AA; Mitchell PD; Gura KM; Puder M Ann Surg; 2015 Jan; 261(1):172-9. PubMed ID: 24374535 [TBL] [Abstract][Full Text] [Related]
36. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974 [TBL] [Abstract][Full Text] [Related]
37. Favorable Outcomes of Preterm Infants With Parenteral Nutrition-associated Liver Disease Treated With Intravenous Fish Oil-based Lipid Emulsion. Sorrell M; Moreira A; Green K; Jacob R; Tragus R; Keller L; Quinn A; McCurnin D; Gong A; El Sakka A; Mittal N; Blanco C J Pediatr Gastroenterol Nutr; 2017 May; 64(5):783-788. PubMed ID: 28437326 [TBL] [Abstract][Full Text] [Related]
38. Anti-tumor necrosis factor-α monoclonal antibody alleviates parenteral nutrition-associated liver disease in mice. Li J; Gong YM; Wu J; Wu WJ; Cai W JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2):219-25. PubMed ID: 22275328 [TBL] [Abstract][Full Text] [Related]
39. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. de Meijer VE; Gura KM; Le HD; Meisel JA; Puder M JPEN J Parenter Enteral Nutr; 2009; 33(5):541-7. PubMed ID: 19571170 [TBL] [Abstract][Full Text] [Related]
40. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. Burns DL; Gill BM JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]